The critical window for treating stroke just got a bit wider, thanks to a $50.0M Series d funding round for Rapid Medical. The company, which develops advanced neurovascular devices, announced the new capital infusion to further its work in improving patient safety and procedural efficiency.
Rapid Medical's technology focuses on interventional devices that are fully visible and adjustable within the brain, a unique capability designed to allow clinicians to tailor procedures to each patient. This approach aims to expand what's possible in neurovascular treatment, where precision and speed are paramount.
